首页> 外文期刊>Gastroenterology research and practice >Current Role of Minimally Invasive Radical Cholecystectomy for Gallbladder Cancer
【24h】

Current Role of Minimally Invasive Radical Cholecystectomy for Gallbladder Cancer

机译:目前对胆囊癌微创自由基胆囊切除术的目前作用

获取原文
获取原文并翻译 | 示例
           

摘要

Background. For Tis and T1a gallbladder cancer (GbC), laparoscopic cholecystectomy can provide similar survival outcomes compared to open cholecystectomy. However, for patients affected by resectable T1b or more advanced GbC, open approach radical cholecystectomy (RC), consisting in gallbladder liver bed resection or segment 4b-5 bisegmentectomy, with locoregional lymphadenectomy, is considered the gold standard while minimally invasive RC (MiRC) is skeptically considered. Aim. To analyze current literature on perioperative and oncologic outcomes of MiRC for patients affected by GbC. Methods. A Medline review of published articles until June 2016 concerning MiRC for GbC was performed. Results. Data relevant for this review were presented in 13 articles, including 152 patients undergoing an attempt of MiRC for GbC. No randomized clinical trial was found. The approach was laparoscopic in 147 patients and robotic in five. Conversion was required in 15 (10%) patients. Postoperative complications rate was 10% with no mortality. Long-term survival outcomes were reported by 11 studies, two of them showing similar oncologic results when comparing MiRC with matched open RC. Conclusions. Although randomized clinical trials are still lacking and only descriptive studies reporting on limited number of patients are available, current literature seems suggesting that when performed at highly specialized centers, MiRC for GbC is safe and feasible and has oncologic outcomes comparable to open RC.
机译:背景。对于TIS和T1A胆囊癌(GBC),与开放的胆囊切除术相比,腹腔镜胆囊切除术可以提供类似的存活结果。然而,对于受重型T1B或更高的GBC影响的患者,在胆囊肝床切除或型4B-5和型患者淋巴结切除术中的开放方法是胆囊肝床切除术(RC)被认为是金标准,而微创RC(MIRC)。持怀疑态度。目的。以GBC影响的患者围手术期和MIRC骨科结果的当前文献分析。方法。发表的文章的MEDLINE审查,直到2016年6月关于GBC的MIRC。结果。对本综述相关的数据呈现在13条文章中,其中包括152名正在进行GBC的MIRC患者。没有发现随机临床试验。该方法在147名患者和5名患者中的腹腔镜。 15名(10%)患者需要转化。术后并发症率为10%,没有死亡率。 11项研究报告了长期存活结果,其中两种研究表明,在将MIRC与匹配的开放式RC进行比较时显示出类似的伊利科学结果。结论。虽然随机临床试验仍然缺乏,但只有关于有限数量的患者报告的描述性研究,目前的文献似乎表明,当在高度专业中心进行时,GBC的MIRC是安全可行的,并且具有与开放式RC相当的肿瘤结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号